Regeneron

Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Fri, 08/9/13 - 10:30 am
wet age-related macular degeneration
diabetic macular edema
Lucentis
Novartis
Roche
Eylea
Regeneron
Optina
Ampio Pharmaceuticals
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thu, 08/8/13 - 09:02 am
Regeneron
REGN-727
dupilumab
Abexinostat
Pharmacyclics
AVI-7288
Sarepta Therapeutics
Regeneron Posts Rare Sales Miss But Counters With Early FDA Filing
TheStreet.com
Tue, 08/6/13 - 11:00 am
Regeneron
FDA
earnings
Eylea
DME
Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
TheStreet.com
Tue, 08/6/13 - 10:54 am
Ampio Pharmaceuticals
Regeneron
Eylea
Optina
DME
6 Oncology-Focused Biotech Growth Engines
Seeking Alpha
Sat, 08/3/13 - 10:33 am
Celgene
Regeneron
Biogen Idec
Gilead Sciences
ONYX Pharmaceuticals
Celldex
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Sat, 08/3/13 - 10:14 am
Regeneron
earnings
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Fri, 08/2/13 - 01:15 pm
earnings
Regeneron
Is This Biopharmaceutical Company Ahead Of Its Time?
Motley Fool
Sat, 07/20/13 - 11:05 am
Regeneron
After Eylea win, Regeneron execs puzzle over R&D scale-up challenge
Fierce Biotech
Thu, 07/18/13 - 11:37 am
Eylea
Regeneron
R&D
Ohr Pharma Plans Regeneron Eye-Drug Rival as Patients Recruited
Bloomberg
Mon, 07/8/13 - 10:59 am
Ohr Pharmaceutical
Regeneron
Squalamine Eye Drops
wet age-related macular degeneration
Roche
Regeneron's New Asthma Drug And Its Fierce Competitors
Seeking Alpha
Thu, 06/27/13 - 12:53 am
Regeneron
asthma
Teva
GSK
Sanofi
dupilumab
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard
The Street
Sat, 06/22/13 - 10:23 am
Regeneron
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard
The Street
Sat, 06/15/13 - 12:59 pm
Regeneron
The First Real Cure in the $25 billion Asthma Market?
Motley Fool
Wed, 06/12/13 - 12:35 pm
asthma
dupilumab
Sanofi
Regeneron
Positive Data on Bayer/REGN's Eye Drug
Yahoo/Zacks
Sat, 06/8/13 - 09:34 am
Bayer
VEGF Trap-Eye
Regeneron
myopic choroidal neovascularization
Regeneron, Bayer reports positive Phase 3 results for Eylea
Yahoo/Fly on the Wall
Thu, 06/6/13 - 10:55 am
Bayer
Eylea
Regeneron
myopic choroidal neovascularization
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha
Tue, 05/28/13 - 09:30 am
asthma
Sanofi
Regeneron
dupilumab
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thu, 05/23/13 - 11:32 am
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
New Asthma Drug Generates Excitement For Patients -- And Its Maker
Forbes
Tue, 05/21/13 - 10:13 am
asthma
Regeneron
dupilumab
Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com
Tue, 05/7/13 - 11:39 am
Biogen Idec
Regeneron
Amgen
Celgene
Gilead

Pages